Form4insider filings, from the source

SEC Form 4 · accession 0000914190-18-000402

REGENERX BIOPHARMACEUTICALS INC · RGRX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
R Don Elsey
Director
Period of report
Sep 11, 2018
Accepted (ET)
Sep 13, 2018 · 5:27 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000707511

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockSep 11, 2018C104,456$0.06A104,456D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Convertible Promissory Note (right to buy)F1$0.06Sep 11, 2018C104,456DSep 12, 2013Sep 11, 2018Common Stock104,4560D
Stock Option (rght to buy)F2$0.16holding————Apr 3, 2019Common Stock50,00050,000D
Stock Option (right to buy)F2$0.21holding————Mar 25, 2021Common Stock120,000120,000D
Stock Option (right to buy)F3$0.19holding————Feb 11, 2022Common Stock100,000100,000D
Stock Option (right to buy)F2$0.36holding————Jun 30, 2022Common Stock100,000100,000D
Stock Option (right to buy)F4$0.64holding————Mar 16, 2023Common Stock100,000100,000D
Stock Option (right to buy)F5$0.28holding————Sep 1, 2027Common Stock125,000125,000D
Stock Option (right to buy)F6$0.21holding————Jul 17, 2028Common Stock200,000200,000D

Explanation of responses